Equilibre Biopharmaceuticals B.V.

Epilepsy and Focal Seizures

Research activity is centered on epilepsy, with emphasis on focal onset seizures in people receiving ongoing anti-seizure medication. The sponsor’s clinical interest lies in adjunctive therapy for seizure control and symptom management.

  • Seizure disorders
  • Focal onset seizures
  • Adjunctive anti-seizure treatment

The sponsor is active across multiple research sites in Europe and other countries, with clinical work focused on treatment options for individuals whose seizures persist despite standard medication.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy

    Not recruiting

    1 1
    Investigated drugs:
    Czechia France Italy Lithuania The Netherlands Poland +2